Portola Pharmaceuticals announces IndexXa review update
Monday, August 22, 2016
Portola pharmaceuticals announces validation of marketing authorization application (maa) by European Medicines Agency (ema) for indexxa (andexanet alfa), a factor xa inhibitor antidote.
Maa for IndexXa submitted to EMA and has been accepted for review.
Source : reuters.com
